Keratosis Pilaris (Strawberry Skin): Causes, Best Treatments, What Actually Works

Dermatological conditions are frequently misunderstood through colloquial branding. Perhaps no condition suffers from this more than keratosis pilaris (KP), commonly referred to in patient forums and social media as "strawberry legs," "strawberry skin," or "chicken skin." Often misdiagnosed by patients as persistent body acne or shaving-induced folliculitis, KP is a highly prevalent follicular hyperkeratinization disorder that affects roughly 40% of the global adult population and up to 50% to 80% of adolescents.

For patients looking for a direct answer: Keratosis pilaris is a benign, genetic follicular disorder characterized by the accumulation of excess keratin within the hair follicle opening, forming a plug that results in rough, pinhead-sized, flesh-colored or red papules on the upper outer arms, thighs, and buttocks. It is fundamentally linked to filaggrin-gene mutations causing skin barrier dysfunction, and it frequently coexists with dry skin (xerosis) and atopic dermatitis (eczema). KP is not acne, it is not an infection, and it is not caused by poor hygiene, which is why aggressive scrubbing and hot water worsen the condition and must be stopped immediately. While it often improves spontaneously with age, managing it in the interim requires a structured, evidence-ranked treatment ladder. A randomized controlled trial (RCT) found that a 10% lactic acid cream achieved a 66% reduction in papules over 12 weeks, significantly outperforming a 5% salicylic acid cream, which achieved a 52% reduction. Accordingly, a JDD survey of board-certified dermatologists found lactic acid to be the most frequently recommended first-line agent (44%), followed by salicylic acid (21%) and urea (another study supports 20% urea). If topicals plateau, topical retinoids (adapalene, tretinoin, tazarotene) can be introduced. For the persistent redness (KP rubra) rather than the bumps, vascular lasers and light devices (pulsed-dye, long-pulsed Nd:YAG, long-pulsed alexandrite, and IPL) can help; an 810-nm diode laser improved texture and roughness — though not redness — in a JAMA Dermatology RCT. Treatment takes 4 to 12 weeks to show results, and over 60% of patients experience a relapse within 3 months of stopping therapy, making consistent maintenance the clinical rule. Topical retinoids must be avoided during pregnancy, during which keratolytics like lactic acid and urea serve as the primary safe options.

To establish an effective long-term routine for KP, we must analyze its cellular causes, evaluate the head-to-head clinical trial data for keratolytics, understand when to escalate to retinoids or lasers, and outline the safety considerations for pregnancy and darker skin.

---

What is keratosis pilaris and what actually causes it?

Keratosis pilaris is an autosomal dominant disorder of follicular keratinization. Histologically, the condition is defined by three hallmark features:

1. Follicular Hyperkeratosis: The excessive production and retention of keratin within the infundibulum (opening) of the hair follicle.
2. Keratin Plugging: The formation of a dense, laminated keratin plug that distends the follicle wall and traps the growing hair shaft (often forcing the hair to coil beneath the plug).
3. Perifollicular Erythema: Mild, chronic inflammatory infiltration around the follicle, which manifests clinically as a red or purple halo surrounding the bump.

                  Healthy vs. Keratosis Pilaris Hair Follicle
                  
       Healthy Follicle                      Keratosis Pilaris Follicle
       
         │   Hair Shaft                         *   *   *  ◄─── Stratum Corneum
         │                                    ┌─*─*─*─*─┐       Hyperkeratosis
         │                                    │  * * *  │ ◄─── Laminated Keratin Plug
       ┌─┼─────┐                              ├─────────┤      (distends follicle)
       │ │     │                              │   \     │ ◄─── Coiled, trapped hair
       │ └─┐   │                              │  └─┐   │
       │   │   │                              │    │   │
       └───┴───┘                              └────┴───┘

The Genetic & Molecular Rationale

For decades, KP was viewed as a minor cosmetic annoyance. However, molecular research has identified a clear genetic foundation. KP is strongly associated with loss-of-function mutations in the FLG (filaggrin) gene.

Filaggrin is a structural protein essential for the aggregation of keratin intermediate filaments in the stratum corneum and the generation of natural moisturizing factors (NMFs) through its degradation.

When filaggrin is deficient:

• The skin barrier is structurally compromised, leading to increased transepidermal water loss (TEWL) and severe dryness.
• The normal desquamation (shedding) process is disrupted. Dead skin cells inside the hair follicle fail to separate and instead clump together, forming a hard, plug-like mass.
• This barrier defect explains why KP is highly comorbid with other atopic conditions: KP frequently co-occurs with atopic dermatitis and ichthyosis vulgaris (both also linked to filaggrin), though KP by itself is not considered diagnostic of either.

Clinical Variants

While the standard presentation involves small, rough bumps on the upper arms, clinicians recognize several distinct variants of the condition:

• Keratosis Pilaris Rubra: Characterized by pronounced, bright red perifollicular inflammation. The skin between the bumps is often flushed, mimicking a localized sunburn.
• Keratosis Pilaris Alba: Bumps are white, grey, or flesh-colored, with minimal underlying redness, typical in patients with dry, non-reactive skin.
• Keratosis Pilaris Rubra Faceii: A facial variant where erythema and hyperkeratotic papules appear on the cheeks, forehead, and jawline, frequently misdiagnosed as rosacea or keratosis pilaris-adjacent acne.
• Keratosis Pilaris Atrophicans: A rare group of genetic variants where keratin plugging eventually leads to follicular atrophy, permanent hair loss, and scarring (e.g., ulerythema ophryogenes, which causes scarring and hair loss in the outer eyebrows).

---

Does keratosis pilaris ever go away on its own?

The natural history of keratosis pilaris is highly age-dependent.

• Onset: The condition typically manifests during early childhood (before age 10) in approximately 50% of cases, and during adolescence (around puberty) in the remaining cohort.
• Peak Severity: Symptoms and lesion counts typically peak during puberty and adolescence, when hormonal fluctuations (particularly increased androgen levels) stimulate sebum production and keratinocyte turnover.
• Resolution: In a significant portion of patients, KP undergoes spontaneous, gradual improvement or complete resolution during the third and fourth decades of life (ages 20 to 40).

The Relapse Reality

For patients who continue to experience KP into adulthood, the concept of a "cure" must be replaced with the concept of "management."

A study published in the Journal of Drugs in Dermatology (JDD) surveying dermatologist treatment outcomes noted that over 60% of patients experience a complete recurrence of symptoms within 3 months of discontinuing their topical treatment routine.

Once active therapy is stopped, the underlying genetic barrier dysfunction remains, and the hair follicles inevitably begin re-accumulating keratin plugs. Consequently, once smooth skin is achieved, patients must transition from a twice-daily treatment protocol to a twice-weekly maintenance protocol to prevent relapse.

---

The evidence-ranked KP treatment ladder: moisturizer, keratolytic, retinoid, laser

To manage keratosis pilaris systematically, clinicians utilize a treatment ladder that scales from gentle barrier repair up to energy-based devices:

                  Keratosis Pilaris Treatment Ladder
                  
    Level 4: Vascular Lasers / IPL ───► Targets persistent redness (KP Rubra)
    Level 3: Topical Retinoids ────────► Speeds cell turnover (Adapalene/Tretinoin)
    Level 2: Keratolytic Acids ────────► Dissolves plugs (Lactic, Salicylic, Urea)
    Level 1: Gentle Barrier Repair ────► Minimizes TEWL, softens skin texture

Level 1: Gentle Barrier Repair

The baseline of all KP therapy is increasing skin hydration to soften the keratin plugs and reduce follicular friction.

• Protocol: Apply thick, ceramide-rich, fragrance-free emollient creams within 5 minutes of bathing to damp skin to trap moisture.
• Goal: Reduces the rough texture and itchiness, but rarely clears the physical bumps.

Level 2: Keratolytic Acids (The Workhorse Step)

Keratolytics are chemical agents that break down the intercellular cement holding the stratum corneum together, actively dissolving the keratin plugs. The three primary agents are lactic acid, salicylic acid, and urea.

• Lactic Acid (Alpha-Hydroxy Acid): Acts as a humectant and exfoliant.
• Salicylic Acid (Beta-Hydroxy Acid): Lipophilic nature allows it to penetrate deep inside the sebum-rich hair follicle to dissolve the plug.
• Urea: A natural moisturizing factor component that dissolves keratin proteins while drawing water into the stratum corneum.

Level 3: Topical Retinoids

If keratolytics fail to flatten the bumps, topical retinoids (such as over-the-counter adapalene 0.1% gel, or prescription tretinoin 0.025%–0.05% and tazarotene 0.05%) are introduced.

• Mechanism: Retinoids bind to nuclear retinoic acid receptors to regulate gene expression, normalizing the differentiation of follicular keratinocytes and speeding up cell turnover. This prevents cells from sticking together inside the follicle.
• Caveat: Retinoids are highly irritating and can trigger significant dryness and redness, potentially worsening perifollicular inflammation if not layered over a thick moisturizer. They are strictly contraindicated in pregnancy.

Level 4: Vascular Lasers and IPL

For patients whose primary complaint is the persistent, cosmetic redness (KP rubra) rather than the rough texture, topicals are often ineffective. These patients are escalated to light-based devices.

• Target: Lasers target the hemoglobin within the dilated capillary networks surrounding the hair follicles.
• Devices: Pulsed Dye Laser (PDL, 595-nm), Nd:YAG (1064-nm), long-pulsed Alexandrite, and Intense Pulsed Light (IPL).

---

Lactic acid vs salicylic acid vs urea: which first and why?

Choosing between the three primary keratolytics should not be an exercise in trial-and-error. We can rank these ingredients based on direct clinical trial evidence and dermatologist prescribing patterns.

The Head-to-Head Trial: 10% Lactic Acid vs. 5% Salicylic Acid

A randomized controlled trial published in PMC (PMC4354723) compared the efficacy of a 10% ammonium lactate (lactic acid) cream against a 5% salicylic acid cream in a split-body design over 12 weeks.

• Method: Patients applied 10% lactic acid to the affected area of one arm and 5% salicylic acid to the other arm, twice daily.
• Results: Both creams achieved significant clearance of hyperkeratotic papules. However, 10% lactic acid demonstrated a statistically superior clearance rate of 66% papule reduction compared to 52% for the 5% salicylic acid cream.
• Erythema & Texture: Lactic acid also outscored salicylic acid in reducing perifollicular redness and improving skin softness, likely due to its superior humectant (water-binding) properties, whereas salicylic acid occasionally caused localized dryness.

The Role of Urea

Urea is a highly effective keratolytic, particularly at concentrations of 10% to 20%. A 2024 study (McCormick et al., Journal of Drugs in Dermatology) evaluated a 20% urea moisturizing cream for moderate-to-severe KP, showing rapid softening of texture and reduction in bump count within 4 weeks.

• At lower concentrations (under 10%), urea acts primarily as a humectant.
• At higher concentrations (20% to 40%), urea acts as a powerful keratolytic that denatures the hydrogen bonds of keratin proteins, making it highly effective for stubborn, heavily plugged cases.
• Histologically, urea works by breaking down the cross-linked disulfide bonds in keratin, rendering the plugs soft and easily sheddable during gentle cleansing.

Prescribing Patterns: The JDD Survey

These trial outcomes match real-world clinical practice. A survey of board-certified dermatologists published in the Journal of Drugs in Dermatology (JDD) reported the following first-line preferences for keratosis pilaris:

       Dermatologist First-Line KP Recommendations (JDD 2023 Survey)
       
       Lactic Acid (Ammonium Lactate) ─────────────► 43.6%   ◄── most-used
       Salicylic Acid (BHA) ───────────────────────► 20.7%
       Energy-Based Devices / Lasers ──────────────►  8.8%
       
       Urea creams, topical retinoids, and plain OTC moisturizers
       account for most of the remaining first-line picks.

Based on this evidence, the clinical recommendation is to start with a 10% to 12% lactic acid lotion (such as over-the-counter AmLactin) or a 15% to 20% urea cream as first-line therapy. Salicylic acid (such as Cerave SA) is an excellent alternative, particularly for patients who also present with active body breakouts.

---

Lasers and IPL for KP redness: who actually benefits?

When patients present with keratosis pilaris rubra, they are often frustrated by the fact that their arms look bright red or purple even after using keratolytics to make the skin completely smooth. This occurs because keratolytics dissolve the keratin plug but do not affect the underlying dilated blood vessels.

For these patients, energy-based devices are the only clinically validated solution.

1. The 810-nm Diode Laser Evidence

A randomized clinical trial published in JAMA Dermatology (Ibrahim et al., 2015) evaluated the efficacy of a long-pulsed 810-nm diode laser for the treatment of KP.

• Method: Patients received three laser sessions at 4-week intervals on one randomly selected arm, while the contralateral arm served as an untreated control.
• Outcomes: The laser-treated arms showed a statistically significant improvement in skin texture and roughness/bumpiness, but baseline erythema (redness) was not improved. The 810-nm diode laser targets the follicle and papule, not the dilated perifollicular blood vessels that cause the redness, and the trial enrolled Fitzpatrick skin types I–III.
• Durability: The texture improvement persisted at the 12-week post-treatment follow-up. For the redness of KP rubra, devices that target hemoglobin — pulsed-dye laser (PDL), long-pulsed Nd:YAG, long-pulsed alexandrite, and IPL (below) — are the better-matched tools.

2. Intense Pulsed Light (IPL) Sham-Controlled Trial

A randomized, double-blind, sham-controlled trial published in the Journal of Clinical and Aesthetic Dermatology (JCAD) evaluated IPL for KP on the upper arms.

• Method: Patients received four IPL sessions (using a 560-nm filter to target vascular redness) on one arm and a sham treatment on the other.
• Outcomes: The IPL-treated arms achieved a significant reduction in perifollicular redness and a highly visible flattening of the bumps, outperforming the control side.
• Safety: IPL proved highly tolerable, with transient redness lasting less than 24 hours and no reported cases of scarring or permanent pigment changes.

Patient Selection for Lasers

Lasers should be reserved for patients who meet the following criteria:

• They have completed a 12-week course of topical keratolytics and have achieved smooth skin texture, but have persistent perifollicular redness (KP rubra).
• They understand the cost: laser treatments for KP are considered cosmetic and typically cost $250 to $500 per session, requiring 3 to 5 sessions.
• They have a stable skin barrier. If active eczema or severe dryness is present on the arms, laser heat can trigger a flare-up.

---

What to stop doing (scrubbing, hot water) and the pregnancy caveat

Managing keratosis pilaris requires patients to stop common skincare habits that damage the skin barrier.

1. Stop Physical Scrubbing

When patients feel rough bumps on their arms, their immediate reaction is to scrub them off using abrasive loofahs, physical body scrubs, or exfoliating gloves.

• Why it fails: KP is a structural barrier defect, not a hygiene problem. Physical scrubbing strips the lipid barrier, worsens dryness, and triggers a defensive response where the skin produces more keratin to protect itself.
• Furthermore, scrubbing tears at the inflamed follicular openings, leading to localized bleeding, microscopic scarring, and post-inflammatory hyperpigmentation.
• The Rule: Replace all physical scrubs with chemical keratolytics. Use your hands to wash with a soap-free, hydrating body wash.

2. Stop Hot Showers

Prolonged exposure to hot water melts away the skin's natural sebum and intercellular lipids, accelerating trransepidermal water loss and worsening the follicular hyperkeratosis.

• The Rule: Limit showers to 5 to 10 minutes using lukewarm water. Apply your keratolytic moisturizer immediately after patting dry, while the skin is still damp.

3. The Pregnancy Safety Protocol

Pregnancy is a common trigger for KP flare-ups due to hormonal shifts that accelerate keratinization. However, the standard treatment ladder must be modified during pregnancy and breastfeeding (our full aesthetic treatments in pregnancy and breastfeeding guide covers the broader rules):

• Topical Retinoids (Contraindicated): Adapalene, tretinoin, and tazarotene must be discontinued immediately due to the potential risk of systemic absorption and teratogenicity.
• Salicylic Acid (Cautious Use): High-concentration, large-surface-area application of salicylic acid should be avoided. While low-strength (under 2%) spot treatments are generally safe, full-body use of 5% salicylic acid cream is not recommended during pregnancy.
• Lactic Acid & Urea (Preferred): Lactic acid (up to 12%) and urea (up to 20%) are the preferred, pregnancy- and breastfeeding-compatible options. They have minimal systemic absorption, are not known to carry teratogenic risk, and actively support the skin barrier during hormonal changes.

4. Skin of Color Considerations

In Fitzpatrick skin types IV through VI, any inflammation around the hair follicle can lead to dark brown spots (perifollicular PIH).

• Aggressive keratolytics or high-energy lasers can trigger this pigment cascade.
• For darker skin, start with lower concentrations of keratolytics (e.g., 5% to 10% lactic acid) and use vascular lasers at conservative settings with longer pulse durations to protect the epidermal melanocytes, following the broader skin-of-color safety protocol for energy devices.

---

FAQ Section

Does keratosis pilaris ever go away on its own?

Yes. Keratosis pilaris typically peaks in severity during puberty and adolescence, and then undergoes a gradual, spontaneous improvement or complete clearance in many patients during their 20s and 30s. However, for some adults, it persists chronically and requires ongoing maintenance therapy to remain clear.

What is the best cream for keratosis pilaris?

The best cream is one containing evidence-backed keratolytic ingredients, which dissolve the keratin plugs. Look for over-the-counter or prescription lotions containing lactic acid (10%–12%), urea (10%–20%), or salicylic acid (2%–5%). Creams containing ceramides are also helpful to repair the genetic skin barrier defect associated with KP.

Is lactic acid or salicylic acid better for KP?

Clinical evidence supports lactic acid as the superior option. In a 12-week head-to-head randomized controlled trial, a 10% lactic acid cream achieved a 66% reduction in KP papules compared to a 52% reduction for a 5% salicylic acid cream. Lactic acid also provides superior hydration, whereas salicylic acid can sometimes cause localized dryness.

Can a laser treat keratosis pilaris?

Yes, lasers are highly effective, particularly for treating the persistent redness (KP rubra) associated with the bumps. A randomized trial published in JAMA Dermatology confirmed that an 810-nm diode laser significantly improved skin texture and roughness (though not redness). For the redness itself, Intense Pulsed Light (IPL), Pulsed Dye Lasers (PDL), long-pulsed Nd:YAG, and long-pulsed alexandrite are the devices that target the vascular component of the condition.

Why does my KP come back when I stop treatment?

KP is a genetic condition linked to filaggrin-gene mutations that cause a permanent skin barrier defect. Treatments can dissolve the existing keratin plugs and smooth the skin, but they do not alter your genetics. Once you stop applying keratolytics, your hair follicles will slowly re-accumulate keratin, with over 60% of patients experiencing a relapse within 3 months. Continuous maintenance (applying cream 2–3 times a week) is required.

Are retinoids safe for KP in pregnancy?

No. Topical retinoids (including adapalene, tretinoin, and tazarotene) must be avoided during pregnancy due to potential teratogenic risks. If you experience a KP flare-up during pregnancy, switch to safe, evidence-backed alternatives like lactic acid or urea-based moisturizers, which are highly effective and carry no risk to the fetus.

---

Sources

1. American Academy of Dermatology. Keratosis pilaris: Diagnosis and treatment. AAD
2. Epidermal permeability barrier in the treatment of keratosis pilaris (10% lactic acid vs. 5% salicylic acid RCT). PMC4354723. PMC
3. Keratosis Pilaris: Treatment Practices of Board-Certified Dermatologists. J Drugs Dermatol. 2023;22(9):985-990. JDD
4. Ibrahim O, Khan M, Bolotin D, et al. Treatment of keratosis pilaris with 810-nm diode laser: a randomized clinical trial. JAMA Dermatol. 2015;151(2):187-191. PubMed
5. Intense Pulsed-light Therapy Significantly Improves Keratosis Pilaris (randomized sham-controlled trial). J Clin Aesthet Dermatol. 2020;13(10):42-45. JCAD
6. Maghfour J, Ly S, Boucier M, et al. Systematic review of topical and laser therapies for keratosis pilaris. J Dermatolog Treat. 2022;33(5):2501-2509. PubMed
7. Harvard Health Publishing. Keratosis pilaris: Treatment and self-care. Harvard Health